ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $56.7B
1-Year Est. Return 25.69%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+25.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$56.7B
AUM Growth
+$8.88B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,107
New
Increased
Reduced
Closed

Top Buys

1
+$779M
2
+$539M
3
+$522M
4
META icon
Meta Platforms (Facebook)
META
+$487M
5
TSLA icon
Tesla
TSLA
+$414M

Top Sells

1
+$189M
2
+$55.4M
3
+$55M
4
ABBV icon
AbbVie
ABBV
+$35.7M
5
NEE icon
NextEra Energy
NEE
+$32.6M

Sector Composition

1 Technology 37.38%
2 Communication Services 10.74%
3 Consumer Discretionary 10.6%
4 Industrials 8.58%
5 Consumer Staples 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCAT icon
2001
Health Catalyst
HCAT
$124M
$29.5K ﹤0.01%
12,357
+793
SKIN icon
2002
The Beauty Health Co
SKIN
$124M
$29K ﹤0.01%
20,893
+1,341
BHR
2003
Braemar Hotels & Resorts
BHR
$209M
$28.9K ﹤0.01%
10,075
-4
MXCT icon
2004
MaxCyte
MXCT
$84.5M
$28.7K ﹤0.01%
18,529
-2,561
SATL icon
2005
Satellogic
SATL
$456M
$28.7K ﹤0.01%
15,349
+3,561
LPRO icon
2006
Open Lending Corp
LPRO
$171M
$28.6K ﹤0.01%
18,481
+951
SKYX icon
2007
SKYX Platforms
SKYX
$278M
$28.4K ﹤0.01%
13,086
+2,482
POWW icon
2008
Outdoor Holding Co
POWW
$249M
$27.1K ﹤0.01%
15,847
+1,019
KLTR icon
2009
Kaltura
KLTR
$192M
$27.1K ﹤0.01%
16,495
+1,059
GETY icon
2010
Getty Images
GETY
$331M
$27K ﹤0.01%
20,117
+1,288
FFAI
2011
Faraday Future Intelligent Electric
FFAI
$106M
$26.6K ﹤0.01%
26,091
+10,438
STXS icon
2012
Stereotaxis
STXS
$206M
$25.4K ﹤0.01%
11,065
+559
PLX icon
2013
Protalix BioTherapeutics
PLX
$242M
$23.6K ﹤0.01%
13,137
+1,215
ZVIA icon
2014
Zevia
ZVIA
$91M
$23.5K ﹤0.01%
+10,150
ALEC icon
2015
Alector
ALEC
$279M
$22.9K ﹤0.01%
14,672
-759
PNBK icon
2016
Patriot National Bancorp
PNBK
$149M
$22.8K ﹤0.01%
+12,524
IKT icon
2017
Inhibikase Therapeutics
IKT
$253M
$22.6K ﹤0.01%
11,046
+705
MNTK icon
2018
Montauk Renewables
MNTK
$225M
$20.5K ﹤0.01%
12,291
+785
FATE icon
2019
Fate Therapeutics
FATE
$180M
$19.5K ﹤0.01%
19,872
-2,831
BRCC icon
2020
BRC Inc
BRCC
$73.4M
$18.8K ﹤0.01%
16,899
+363
LUCD icon
2021
Lucid Diagnostics
LUCD
$193M
$18K ﹤0.01%
16,471
+4,320
HAIN icon
2022
Hain Celestial
HAIN
$72.8M
$17.7K ﹤0.01%
16,541
+1,063
EXFY icon
2023
Expensify
EXFY
$115M
$16.5K ﹤0.01%
10,923
+698
ELDN icon
2024
Eledon Pharmaceuticals
ELDN
$193M
$15.5K ﹤0.01%
+10,266
ADV icon
2025
Advantage Solutions
ADV
$177M
$15.2K ﹤0.01%
17,229
+1,114
79 80
81
82 83